Search research articles
Contact Us
Filters
Showing results (11-20 of 100) with videos related to
Page
of 10
Sort By:
Comprehensive Therapy
|
April 1, 1986
Nosocomial urinary tract infection
D R Schaberg, M J Zervos
Clinics in Laboratory Medicine
|
March 1, 1996
DNA analysis in the study of fungal infections in the immunocompromised host
M J Zervos, J A Vazquez
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
April 1, 1994
Randomized comparative trial with ampicillin/sulbactam versus cefamandole in the therapy of community acquired pneumonia
D Williams, M Perri, M J Zervos
The Journal of International Medical Research
|
July 23, 2003
Oral telithromycin 800 mg once daily for 5 days versus cefuroxime axetil 500 mg twice daily for 10 days in adults with acute exacerbations of chronic bronchitis
M J Zervos, A M Heyder, B Leroy
Infection Control and Hospital Epidemiology
|
May 1, 1996
Control of endemic glycopeptide-resistant enterococci
L M Dembry, K Uzokwe, M J Zervos
Infectious Agents and Disease
|
December 1, 1995
Nosocomial candidiasis: epidemiology and drug resistance
R Mahayni, J A Vazquez, M J Zervos
Diagnostic Microbiology and Infectious Disease
|
November 1, 1991
Time-kill kinetic studies of ampicillin/sulbactam for beta-lactamase-producing enterococci
J E Patterson, P Farrel, M J Zervos
Infection Control and Hospital Epidemiology
|
December 1, 1996
Long-term survival of vancomycin-resistant Enterococcus faecium on a contaminated surface
H F Bonilla, M J Zervos, C A Kauffman
Journal of Clinical Pharmacy and Therapeutics
|
October 18, 2016
Safety and efficacy of outpatient parenteral antibiotic therapy in an academic infectious disease clinic
G Suleyman, R Kenney, M J Zervos, et al.
Diagnostic Microbiology and Infectious Disease
|
August 1, 1993
In vitro activity of sparfloxacin and clinafloxacin against multidrug-resistant enterococci
M B Perri, J W Chow, M J Zervos
Page
of 10
Search research articles
Search
Showing results (11-20 of 100) with videos related to
Sort By:
Page
of 10
Comprehensive Therapy
|
April 1, 1986
Nosocomial urinary tract infection
D R Schaberg, M J Zervos
Clinics in Laboratory Medicine
|
March 1, 1996
DNA analysis in the study of fungal infections in the immunocompromised host
M J Zervos, J A Vazquez
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
April 1, 1994
Randomized comparative trial with ampicillin/sulbactam versus cefamandole in the therapy of community acquired pneumonia
D Williams, M Perri, M J Zervos
The Journal of International Medical Research
|
July 23, 2003
Oral telithromycin 800 mg once daily for 5 days versus cefuroxime axetil 500 mg twice daily for 10 days in adults with acute exacerbations of chronic bronchitis
M J Zervos, A M Heyder, B Leroy
Infection Control and Hospital Epidemiology
|
May 1, 1996
Control of endemic glycopeptide-resistant enterococci
L M Dembry, K Uzokwe, M J Zervos
Infectious Agents and Disease
|
December 1, 1995
Nosocomial candidiasis: epidemiology and drug resistance
R Mahayni, J A Vazquez, M J Zervos
Diagnostic Microbiology and Infectious Disease
|
November 1, 1991
Time-kill kinetic studies of ampicillin/sulbactam for beta-lactamase-producing enterococci
J E Patterson, P Farrel, M J Zervos
Infection Control and Hospital Epidemiology
|
December 1, 1996
Long-term survival of vancomycin-resistant Enterococcus faecium on a contaminated surface
H F Bonilla, M J Zervos, C A Kauffman
Journal of Clinical Pharmacy and Therapeutics
|
October 18, 2016
Safety and efficacy of outpatient parenteral antibiotic therapy in an academic infectious disease clinic
G Suleyman, R Kenney, M J Zervos, et al.
Diagnostic Microbiology and Infectious Disease
|
August 1, 1993
In vitro activity of sparfloxacin and clinafloxacin against multidrug-resistant enterococci
M B Perri, J W Chow, M J Zervos
Page
of 10